ZLATOMICS BIOTECH

HOME BIOTECH ABOUT PORTFOLIO CONTACT CAREERS NEWS

Past & Current Client Portfolio Examples

Our Work

Incentive-driven Ethereum-like platform decentralizing and accelerating genomics science development.
Exploiting 80% of small (non-biotech) businesses that go unsold to reconstruct biotech enterprises - by leveraging existing assets, not additional capital.
Leveraging molecular chaperones as genomic therapeutic targets in medical research.
Harnessing DNA computers as innovative tools for computation and data storage within biological systems.
Utilizing alternative transcription start sites and transcription termination sites as direct gene regulatory medicines.
Expanding the internal genomic knowledge base of large language models for scientific and applied use.
The influence of DNA on the disease landscape and its implications for personalized nutrition.
With over 150 companies utilizing prime editing technologies, reassessment and correction of the technology's true value is highlighted.
Predicting and prioritizing high-probability outcomes while assisting identification of key proteins to be produced for weight-loss management.
CONTACT US
ASK AI ABOUT PORTFOLIO
STRATEGIC PARTNERSHIP OUR APPROACH NEWS FOUNDER OUR R&D